These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 18045828)
41. Parathyroid hormone is inversely related to endothelin-1 in patients on haemodialysis. Palermo A; Mulè G; Guarneri M; Arsena R; Riccobene R; Lorito MC; Vaccaro F; Cerasola G; Cottone S Nephrology (Carlton); 2008 Dec; 13(6):467-71. PubMed ID: 18518931 [TBL] [Abstract][Full Text] [Related]
42. The clinical significance of parathyroid tissue calcium sensing receptor gene polymorphisms and expression levels in end-stage renal disease patients. Eren PA; Turan K; Berber I; Canbakan M; Kara M; Tellioglu G; Bugan U; Sevinç C; Turkmen F; Titiz MI Clin Nephrol; 2009 Aug; 72(2):114-21. PubMed ID: 19640368 [TBL] [Abstract][Full Text] [Related]
43. The CARE-2 study results: setting the record straight. Qunibi W; Muenz LR; Diaz-Buxo JA Nephrol Dial Transplant; 2008 Dec; 23(12):4081-2; author reply 4082-3. PubMed ID: 18820282 [No Abstract] [Full Text] [Related]
44. PTH, FGF-23 and early CKD. Rodriguez M; Felsenfeld AJ Nephrol Dial Transplant; 2008 Nov; 23(11):3391-3. PubMed ID: 18676347 [No Abstract] [Full Text] [Related]
45. [Chronic kidney disease (CKD) and bone. Targets of serum calcium, phosphate, and parathyroid hormone levels and their controls in maintenance dialysis patients]. Akiba T Clin Calcium; 2009 Apr; 19(4):537-44. PubMed ID: 19329833 [TBL] [Abstract][Full Text] [Related]
46. Study of the relationships between pericarditis and osteopathy in chronic haemodialysis. Makó J; Szücs J; Gaizler G; Lengyel M; Mérei J Int Urol Nephrol; 1983; 15(4):383-7. PubMed ID: 6662655 [TBL] [Abstract][Full Text] [Related]
47. Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism. Esposito MG; Cesare CM; De Santo RM; Cice G; Perna AF; Violetti E; Conzo G; Bilancio G; Celsi S; Annunziata F; Iannelli S; De Santo NG; Cirillo M; Livrea A J Nephrol; 2008; 21 Suppl 13():S92-6. PubMed ID: 18446739 [TBL] [Abstract][Full Text] [Related]
48. Aging and calcium. Fujita T Miner Electrolyte Metab; 1986; 12(3):149-56. PubMed ID: 2425238 [No Abstract] [Full Text] [Related]
50. Free protein S deficiency in hemodialysis patients due to vascular calcifications? Perez-Mijares R; Payan-Lopez J; Guzman-Zamudio JL; Sanchez-Angulo JI; Gomez-Fernandez P; Ramos-Diaz M; Alcala-Rueda M; Silgado-Rodriguez G; Hermosin-Ramos L; Almaraz-Jimenez M Nephron; 1996; 74(2):356-60. PubMed ID: 8893155 [TBL] [Abstract][Full Text] [Related]
51. Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Guideline Working Group, Japanese Society for Dialysis Therapy Ther Apher Dial; 2008 Dec; 12(6):514-25. PubMed ID: 19140852 [No Abstract] [Full Text] [Related]
52. Limbal and corneal calcification in patients with chronic renal failure. Klaassen-Broekema N; van Bijsterveld OP Br J Ophthalmol; 1993 Sep; 77(9):569-71. PubMed ID: 8218054 [TBL] [Abstract][Full Text] [Related]
53. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study. Melamed ML; Eustace JA; Plantinga LC; Jaar BG; Fink NE; Parekh RS; Coresh J; Yang Z; Cantor T; Powe NR Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788 [TBL] [Abstract][Full Text] [Related]
54. Pre-transplant calcium-phosphate-parathormone homeostasis as a risk factor for early graft dysfunction. Ahmadi F; Ali-Madadi A; Lessan-Pezeshki M; Khatami M; Mahdavi-Mazdeh M; Razeghi E; Maziar S; Seifi S; Abbasi M Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):54-8. PubMed ID: 18087123 [TBL] [Abstract][Full Text] [Related]
56. Bone-vascular axis in chronic kidney disease: a reality? London GM Clin J Am Soc Nephrol; 2009 Feb; 4(2):254-7. PubMed ID: 19176792 [No Abstract] [Full Text] [Related]
57. Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients. Avci E; Coskun S; Cakir E; Kurt Y; Ozgur Akgul E; Bilgi C Ren Fail; 2008; 30(8):784-90. PubMed ID: 18791952 [TBL] [Abstract][Full Text] [Related]
58. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience]. Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031 [TBL] [Abstract][Full Text] [Related]
59. Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease. Raggi P; Kleerekoper M Clin J Am Soc Nephrol; 2008 May; 3(3):836-43. PubMed ID: 18322050 [TBL] [Abstract][Full Text] [Related]
60. Calcium malabsorption does not cause secondary hyperparathyroidism. Nordin BE; Morris HA; Horowitz M; Coates PS; O'Loughlin PD; Need AG Calcif Tissue Int; 2009 Jul; 85(1):31-6. PubMed ID: 19488668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]